General Information of DTT (ID: TT9E8HR)

DTT Name Osteoclast differentiation factor (ODF) DTT Info
Gene Name TNFSF11

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
1 Approved Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Denosumab DMNI0KO Drug-induced osteoporosis Approved [1]
------------------------------------------------------------------------------------
2 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
ALX-0141 DMBGI74 Osteoporosis FB83.0 Phase 1 [2]
CEP-37251 DMYXQBF Bone metastases 2D50 Phase 1 [3]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Mullard A: 2010 FDA drug approvals. Nat Rev Drug Discov. 2011 Feb;10(2):82-5.
2 Clinical pipeline report, company report or official report of Ablynx.
3 This week in therapeutics Cancer. SciBX 3(40); doi:10.1038/scibx.2010.1202. Oct. 14, 2010